Logo Image
NEWS
Special ReportsAll NewsFDA BriefsOncology IconsThe Targeted Pulse
CONFERENCES
Conference CoverageConference ListingData Dialogue with the Oncology Brothers
MEDIA
All VideosCase-Based Peer PerspectivesEvolving Paradigms in OncologyExpert Perspective Virtual Tumor BoardInterviewsInvestigator PerspectivesMedical World NewsPivotal Practice Views with the Oncology BrothersPodcastsPractice PlaybookShortsVideo Series
PUBLICATIONS
All PublicationsEvolving ParadigmsPeers & Perspectives in OncologyTargeted Therapies in Oncology
More
CASE-BASED ROUNDTABLE
PARTNERS
RESOURCES
CME/CEClinical TrialsEventsPrecision Medicine PerspectivesPress ReleasesSponsored ContentTreatment Resources
SUBSCRIBE
  • NEWS
  • CONFERENCES
  • MEDIA
  • PUBLICATIONS
  • CASE-BASED ROUNDTABLE
  • PARTNERS
  • RESOURCES
  • SUBSCRIBE
  • BRAIN CANCER
  • BREAST CANCER
    • HER2 Breast Cancer
  • COMMUNITY ONCOLOGY PRACTICE
  • GENITOURINARY CANCERS
    • Bladder Cancer
    • Prostate Cancer
    • Renal Cell Carcinoma
  • GENOMIC TESTING
    • Liquid Biopsies
  • GI CANCERS
    • Pancreatic Cancer
    • Colorectal Cancer
    • Gastric Cancer
    • GIST
    • HCC
  • GYNECOLOGIC CANCERS
    • Cervical Cancer
    • Endometrial Cancer
    • Ovarian Cancer
  • HEAD & NECK CANCERS
  • HEMATOLOGY
    • Bone Marrow & Stem Cell Transplant
  • IMMUNOTHERAPY
    • CAR T-Cell Therapy
  • LEUKEMIAS
    • AML
    • Chronic Lymphocytic Leukemia
    • Chronic Myeloid Leukemia
  • LUNG CANCER
    • MET-Targeted Therapy
    • Small Cell Lung Cancer
    • Biomarker-Driven Lung Cancer
    • EGFR+ Lung Cancer
  • LYMPHOMAS
    • DLBCL
    • Follicular Lymphoma
    • Mantle Cell Lymphoma
  • MPNs
  • MULTIPLE MYELOMA
  • NTRK GENE FUSIONS
  • ONCOLOGY POLICY
  • SARCOMA
  • SKIN CANCERS
    • Melanoma
  • THYROID CANCERS
Spotlight -
Community Oncology Practice|
Oncology Policy|
Myeloma|
CLL|
Genomic Testing|
GU Cancers
Advertisement

Inna Gong, MD, PhD

Advertisement

Articles by Inna Gong, MD, PhD

Less Than 5% of Older Adults Joined Blood Cancer Trials, Study Shows

ByAndrea Eleazar, MHS,Inna Gong, MD, PhD
February 10th 2026

SEER-Medicare data show just 4% of older adults with blood cancers enter clinical trials, revealing disparities and fixable access barriers.

Advertisement

Latest Updated Articles

  • Decentralized Clinical Trials: Reducing the Logistical Burden of Participation
    Decentralized Clinical Trials: Reducing the Logistical Burden of Participation

    March 27th 2026

  • Less Than 5% of Older Adults Joined Blood Cancer Trials, Study Shows
    Less Than 5% of Older Adults Joined Blood Cancer Trials, Study Shows

    February 10th 2026

  • Blood Cancer Trials Aren’t Reaching Most Older Patients
    Blood Cancer Trials Aren’t Reaching Most Older Patients

    February 11th 2026

  • Why Haven't Trial Participation Rates Improved?
    Why Haven't Trial Participation Rates Improved?

    March 23rd 2026



Advertisement
Advertisement

Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways

1

2026 ASCO Plenary Delivers Practice-Changing Progress

2

ASCO 2026 GI Cancer Highlights: Beyond the LBAs

3

FDA Grants ODD to LRRC15-Targeting ADC SOT106 for Osteosarcoma

4

FDA Clears US Enrollment for Ateganosine Phase 2 NSCLC Trial Expansion

5

FDA Grants Fast Track Designation to VS-7375 for KRAS G12D–Mutated NSCLC

  • About Us
  • Advertise
  • Contact Us
  • CureToday.com
  • CancerNetwork.com
  • OncLive.com
  • OncNursingNews.com
  • Do Not Sell My Information
  • Privacy
  • Terms & Conditions
  • Editorial Board
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us